Michel Dahan, SVP, Chief Operating Officer at Akebia Therapeutics, Inc. (AKBA), sold 14,547 shares at $3.40 ($49K) on 2021-03-01, disclosed to the SEC on 2021-03-02.
Seasonal sale ($49k) by SVP, Chief Operating Officer — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.40 | 6,602 | $22K | 45.4% |
| 2 | $3.40 | 7,945 | $27K | 54.6% |
| Total | $3.40 avg | 14,547 | $49K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $16K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $233K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $18K | — | Filing → |